Company: GRCE
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001140361-25-041804
Chunk: 44

Company: Grace Therapeutics, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Item 8
Chunk 44
---
 base salary plus target bonus then in effect, and (ii) pay or reimburse his COBRA premiums for eighteen (18) months on terms no less favorable than those in effect on November 12, 2025. Any unvested and outstanding equity awards held by Mr. Kohli shall be fully vested and exercisable upon termination by the Company without Cause in connection with or within twelve (12) months following a Change in Control of the Company.

   Executive Officer Employment Agreements

   On November 12, 2025, the Company entered into employment agreements with each of its other executive officers, consisting of (i) Robert J. DelAversano, the Company’s Principal Financial Officer and Vice President, Finance (the “DelAversano Letter Agreement”), (ii) Amresh Kumar, the Company’s Vice President, Program Management (the “Kumar Letter Agreement”), (iii) Carrie D’Andrea, the Company’s Vice President, Clinical Operations (the “D’Andrea Letter Agreement”), and, (iv) R. Loch Macdonald, the Company’s Chief Medical Officer (the “Macdonald Letter Agreement” and, together with the DelAversano Letter Agreement, the Kumar Letter Agreement and the D’Andrea Letter Agreement, the “Letter Agreements”). The Letter Agreements supersede in their entirety any prior employment agreements or arrangements between the executive officers and the Company.

   Pursuant to the respective Letter Agreements:

     ●

     Mr. DelAversano is entitled to receive an annual base salary of $306,360 and an annual discretionary bonus of up to 30% of his annual base salary as determined by the Board of Directors of the Company (the “Board”). In order to earn a discretionary bonus, Mr. DelAversano must remain employed with the Company throughout the year for which the bonus is paid and must be actively employed in good standing on the date on which the bonus is paid.

     ●

     Mr. Kumar is entitled to receive an annual base salary of $310,000 and an annual discretionary bonus of up to 30% of his annual base salary as determined by the Board. In order to earn a discretionary bonus, Mr. Kumar must remain employed with the Company throughout the year for which the bonus is paid and must be actively employed in good standing on the date on which the bonus is paid.

     ●

     Ms. D’Andrea is entitled to receive an annual base salary of $310,000 and an annual discretionary